Details of the Drug | DrugMAP

General Information of Drug (ID: DMRZHKL)

Drug Name

REG1

Indication

Disease Entry	ICD 11	Status	REF
Acute coronary syndrome	BA41	Phase 3	[1]
------------------------------------------------------------------------------------

Structure

3D MOL is unavailable

2D MOL

Chemical Identifiers

Formula: C20H40N3O11P
Canonical SMILES: COCCOC(=O)NCCCCC(C(=O)NCCCCCCOP(=O)(O)O)NC(=O)OCCOC
InChI: 1S/C20H40N3O11P/c1-30-13-15-32-19(25)22-11-7-5-9-17(23-20(26)33-16-14-31-2)18(24)21-10-6-3-4-8-12-34-35(27,28)29/h17H,3-16H2,1-2H3,(H,21,24)(H,22,25)(H,23,26)(H2,27,28,29)
InChIKey: QGVYYLZOAMMKAH-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 86278323
CAS Number: 959716-28-0
TTD ID: D05ALP

References

1	ClinicalTrials.gov (NCT01848106) A Study To Determine the Efficacy and Safety of REG1 Compared to Bivalirudin in Patients Undergoing PCI. U.S. National Institutes of Health.